Academic studies

Experts from industry and academia recently came together to celebrate 30 years since the original CANTAB neurological tests were developed.

CANTAB 30 marks three decades of neuroscience research which has seen over 1,800 peer-reviewed papers published in high impact journals using the touchscreen CANTAB tests. The sensitive measures have been applied to more than 100 research areas including Alzheimer's disease, schizophrenia and many other disorders where cognitive function is affected.

Select from the CANTAB 30 speakers below to view their presentations in full.

Translational Neuroscience


Trevor Robbins

 

Developmental Disorders


 

Ian Goodyer


 

David Coghill

 

Alzheimer's Disease


 

Mathew Summers

 

Affective Disorders


 

Bill Deakin


 

Marcus Munafo

 

Schizophrenia


 

Eileen Joyce


 

Christos Pantelis

 

Future Impact


 

Jim Lumsden


 

Molly Crockett


 

Rebecca Elliott


 

Barbara Sahakian

 

View the photographs from the day

Cantab 30

  • Clients
  • Clients
  • Clients
  • Clients
  • Clients
  • Clients